- 全部删除
- 您的购物车当前为空
VEGFR-2-IN-66 (Compound 6) 是一种口服活性的VEGFR-2抑制剂,其IC50为0.509 µM,对MCF-7细胞增殖的IC50为7.48 μM。VEGFR-2-IN-66 通过阻滞细胞周期、诱导凋亡 (Apoptosis) 和调节基因表达来展现其抗癌活性,适用于乳腺癌研究领域。
VEGFR-2-IN-66 (Compound 6) 是一种口服活性的VEGFR-2抑制剂,其IC50为0.509 µM,对MCF-7细胞增殖的IC50为7.48 μM。VEGFR-2-IN-66 通过阻滞细胞周期、诱导凋亡 (Apoptosis) 和调节基因表达来展现其抗癌活性,适用于乳腺癌研究领域。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 待询 | |
50 mg | 待询 | 待询 |
VEGFR-2-IN-66 相关产品
产品描述 | VEGFR-2-IN-66 (Compound 6) is an orally active VEGFR-2 inhibitor with an IC50 of 0.509 µM and an IC50 value of 7.48 μM for inhibiting MCF-7 cell proliferation. Its anticancer activity is exerted through cell cycle arrest, induction of apoptosis (Apoptosis), and modulation of gene expression, making it suitable for breast cancer research. |
靶点活性 | VEGFR2:509 nM |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容